Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Adolescent and young adult rare disease patients often struggle with the switch to the adult health care system. Experts at t…
On March 6, McKenzie starts leading CSL, whose life-saving medicines are used in more than 100 countries. He begins his new r…
EURORDIS celebrates the patients, policy makers, scientists and others who dedicate their lives to the rare disease cause.
The first cohort of a new CSL internship program in Australia recently completed a three-month stint with the biotech company…
In Marburg, Germany, CSL Behring employees wanted to light up a local landmark to celebrate Rare Disease Day. But to be respo…
On the latest episode of The New Horizon Talks, experts discuss advancing patient access to specialized care and the European…
Test your knowledge of hereditary angioedema, a rare disease that causes unpredictable swelling.
Medical innovation has soared, but a new coalition says more coordination and collaboration are needed to speed progress for …
Your medical journey is uniquely your own. Are you ready to share your story? Get started with this writing exercise from Pul…
Americas
Asia Pacific
Middle East
Europe